Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2014
09/30/2014US8846866 Aldehyde tags, uses thereof in site-specific protein modification
09/30/2014US8846862 Microwave-assisted peptide synthesis
09/30/2014US8846861 Peptide clearing agents
09/30/2014US8846621 Compositions and methods for treating diseases associated with angiogenesis and inflammation
09/30/2014US8846579 Ligand screening and discovery
09/30/2014US8846411 Derivatives, reagents, and immunoassay for detecting levetiracetam
09/30/2014US8846397 Immunoregulation by anti-ILT5 antibodies and ILT5-binding antibody fragments
09/30/2014US8846388 Infectious clones of torque teno virus
09/30/2014US8846341 Marker panels for idiopathic pulmonary fibrosis diagnosis and evaluation
09/30/2014US8846325 Methods of cancer diagnosis and therapy targeted against a cancer stem line
09/30/2014US8846324 In vitro method for diagnosing or predicting hypertension and/or early-stage cardiovascular end-organ damage by determining the concentration of soluble prorenin receptor
09/30/2014US8846050 N-domain of carcinoembryonic antigen and compositions, methods and uses thereof
09/30/2014US8846047 Monoclonal antibodies against HMGB1
09/30/2014US8846046 Low dose methods for treating disorders in which TNFα activity is detrimental
09/30/2014US8846045 Anti-C5a receptor antibodies
09/30/2014US8846043 Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
09/30/2014US8846042 Multi-specific FAB fusion proteins and methods of use
09/30/2014US8846041 Anti-LRP6 antibodies
09/30/2014US8846038 Method for treating synovial sarcoma
09/30/2014US8846037 Antibodies to IL-6 and their uses
09/30/2014US8846036 Antibodies that bind to mammalian NGAL and uses thereof
09/30/2014US8846005 APCDD1 inhibitors for treating, diagnosing or detecting cancer
09/30/2014US8846002 Anti-CD74 immunoconjugates and methods of use
09/30/2014CA2606102C Modulation of antibody effector function by hinge domain engineering
09/30/2014CA2590935C Fc.gamma.riib-specific antibodies and methods of use thereof
09/30/2014CA2535489C Antibodies against factor viii with modified glycosylation in the variable region
09/30/2014CA2506737C Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia (b-cll)
09/30/2014CA2471551C Methods to engineer mammalian-type carbohydrate structures
09/30/2014CA2252439C Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
09/25/2014WO2014153435A1 Methods for treating osteogenesis imperfecta
09/25/2014WO2014153270A1 Treatment of cancer using humanized anti-cd19 chimeric antigen receptor
09/25/2014WO2014153242A1 Compositions having dicamba decarboxylase activity and methods of use
09/25/2014WO2014153195A1 Monoclonal antibodies against antithrombin beta complexed with heparin
09/25/2014WO2014153166A2 Therapeutic use of antibodies to hgf
09/25/2014WO2014153117A2 Antibodies to hgf and compositions containing
09/25/2014WO2014153063A1 AGLYCOSYLATED Fc-CONTAINING POLYPEPTIDES
09/25/2014WO2014153002A1 Bispecific antibodies and uses thereof
09/25/2014WO2014152801A1 Selective uv crosslinking of peptides and functional moieties to immunoglobulins
09/25/2014WO2014152774A1 Methods and compositions for delivering mrna coded antibodies
09/25/2014WO2014152751A1 Multi-layered injectable self-assembling peptide scaffold hydrogels for long-term sustained release of human antibodies
09/25/2014WO2014152715A1 Use of inhibitors of binding between a par-1 receptor and its ligands for the treatment of glioma
09/25/2014WO2014152361A1 Antibodies against human and canine il-13ra2
09/25/2014WO2014152247A1 Improved tnf binding proteins
09/25/2014WO2014152174A1 Modulation of plant immune system function
09/25/2014WO2014151960A2 Methods for controlling t cell proliferation
09/25/2014WO2014151910A1 Heterodimeric bispecific antibodies
09/25/2014WO2014151901A1 Improvement of mammalian cell culture performance through surfactant supplementation of feed media
09/25/2014WO2014151878A2 Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
09/25/2014WO2014151866A1 Compositions and methods for diagnosis and treatment of hepatic cancers
09/25/2014WO2014151834A2 Methods and compositions relating to anti-ccr7 antigen binding proteins
09/25/2014WO2014151747A1 Methods and compositions with immune therapy for treatment of dementia
09/25/2014WO2014151683A1 Gla domains as targeting agents
09/25/2014WO2014151680A1 Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies
09/25/2014WO2014151649A1 Monoclonal antibodies to egfr, and uses therefor
09/25/2014WO2014151644A2 Anti-cd52 antibodies
09/25/2014WO2014151526A1 Biological therapeutics for infection-relating disorders or conditions
09/25/2014WO2014151422A1 Interferon alpha and omega antibody antagonists
09/25/2014WO2014150983A2 Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9
09/25/2014WO2014150973A1 Methods for producing fabs and bi-specific antibodies
09/25/2014WO2014150937A1 Antibody drug conjugates
09/25/2014WO2014150877A2 Anti-tau antibodies and methods of use
09/25/2014WO2014150314A1 Therapeutic uses for vegfr1 antibodies
09/25/2014WO2014149733A1 Pan-ELR+ CXC CHEMOKINE ANTIBODIES
09/25/2014WO2014149477A1 Methods for achieving therapeutically effective doses of anti-cd47 agents
09/25/2014WO2014149425A1 Methods for treating psoriasis using an anti-il-23 antibody
09/25/2014WO2014148895A1 Humanized anti-cd134 (ox40) antibodies and uses thereof
09/25/2014WO2014148627A1 Analysis method for assessing stage of prostate cancer, prostate-cancer stage assessment method, prostate-cancer detection method, and test kit
09/25/2014WO2014148572A1 Cell metastasis or invasion inhibitor
09/25/2014WO2014148444A1 ANTI-DOG IgE MONOCLONAL ANTIBODY, AND LIGHT-CHAIN VARIABLE REGION AND HEAVY-CHAIN VARIABLE REGION OF ANTI-DOG IgE MONOCLONAL ANTIBODY
09/25/2014WO2014147873A1 Antibody that binds specifically with hmgb1 decomposition product, and method and reagent for assaying hmgb1 decomposition product
09/25/2014WO2014147628A1 Bacterial immunoassay
09/25/2014WO2014146778A1 Therapy involving antibodies against claudin 18.2 for treatment of cancer
09/25/2014WO2014146672A1 Therapy involving antibodies against claudin 18.2 for treatment of cancer
09/25/2014WO2014146575A1 Antibodies and methods for treating estrogen receptor-associated diseases
09/25/2014WO2014146487A1 Anti-cell surface ectopic expression monoclonal antibody, preparation method and use thereof
09/25/2014US20140289880 Transgenic chickens
09/25/2014US20140289876 Mice that make heavy chain antibodies
09/25/2014US20140288288 Anti-cd19 antibodies with reduced immunogenicity
09/25/2014US20140288279 M-DC8+ Monocyte Depleting Agent for the Prevention or the Treatment of a Condition Associated with a Chronic Hyperactivation of the Immune System
09/25/2014US20140288278 Chromatography process for resolving heterogeneous antibody aggregates
09/25/2014US20140288277 Compositions and Methods for Comprising an RNA-Specific Fab Library
09/25/2014US20140288276 Humanized anti-ccr2 antibodies and methods of use therefor
09/25/2014US20140288275 Novel heterodimeric proteins
09/25/2014US20140288274 Human monoclonal antibody neutralizing vascular endothelial growth factor receptor and use thereof
09/25/2014US20140288273 Macromolecular compositions that cross the blood-brain barrier and methods of use thereof
09/25/2014US20140288272 Antibody purification and purity monitoring
09/25/2014US20140288267 Compositions and methods for modulating rsv infection and immunity
09/25/2014US20140288161 Urocortin-iii and uses thereof
09/25/2014US20140287952 Protocol for identifying and isolating antigen-specific b cells and producing antibodies to desired antigens
09/25/2014US20140287503 Use of inhibitors of leukotriene b4 receptor blt2 for treating asthma
09/25/2014US20140287463 Engineered pichia strains with improved fermentation yield and n-glycosylation quality
09/25/2014US20140287446 Monoclonal Antibody For Acetylamantadine
09/25/2014US20140287443 Characterization of cho-mif gene and protein, and use thereof
09/25/2014US20140287441 Immunoassay for cyclopropylindole based synthetic cannabinoids, metabolites and derivatives thereof
09/25/2014US20140287431 Antibody specific to profilaggrin c-terminal domain, and use thereof
09/25/2014US20140287426 Antibody and antibody mimetic for visualization and ablation of endogenous proteins
09/25/2014US20140287003 Pharmaceutical formulation for reducing frequency of urination and method of use thereof
09/25/2014US20140286995 NUCLEIC ACID CONSTRUCT COMPRISING NUCLEIC ACID DERIVED FROM GENOME OF HEPATITIS C VIRUS OF GENOTYPE 3a
09/25/2014US20140286987 Methods for controlling t cell proliferation
09/25/2014US20140286976 Chimeric human-llama antigens and methods of use
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 1494